150 related articles for article (PubMed ID: 165827)
21. Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.
Gotto AM; Brown WV; Levy RI; Birnbaumer ME; Fredrickson DS
J Clin Invest; 1972 Jun; 51(6):1486-94. PubMed ID: 4336942
[TBL] [Abstract][Full Text] [Related]
22. [Change in the apoproteins of very low density lipoproteins in the blood in hypertriglyceridemia].
Perova NV; Gerasimova EN; Chernysheva NP; Nikitina NA; Shcherbakova IA
Vopr Med Khim; 1979; 25(2):185-92. PubMed ID: 220803
[TBL] [Abstract][Full Text] [Related]
23. [Studies with 14C-cholesterol in homozygotic hyperlipemia type IIa].
Gärtner U; Altrogge H; Sieg K; Becker K; Bläker F
Verh Dtsch Ges Inn Med; 1975; 81():1434-8. PubMed ID: 179240
[No Abstract] [Full Text] [Related]
24. Solid phase radioimmunoassay of apolipoprotein B (apo B) in normal human plasma.
Thompson GR; Birnbaumer ME; Levy RI; Gotto AM
Atherosclerosis; 1976; 24(1-2):107-18. PubMed ID: 182180
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein B levels and altered lipoprotein composition in diabetes.
Schonfeld G; Birge C; Miller JP; Kessler G; Santiago J
Diabetes; 1974 Oct; 23(10):827-34. PubMed ID: 4371149
[No Abstract] [Full Text] [Related]
26. Metabolism of rat plasma very low density lipoprotein. I. Fate in circulation of the whole lipoprotein.
Eisenberg S; Rachmilewitz D
Biochim Biophys Acta; 1973 Dec; 326(3):378-90. PubMed ID: 4359866
[No Abstract] [Full Text] [Related]
27. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
Bagnall TF; Lloyrd JK
Clin Chim Acta; 1975 Mar; 59(3):271-6. PubMed ID: 165017
[TBL] [Abstract][Full Text] [Related]
28. Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations.
Nestel PJ; Hunt D; Wahlqvist ML
Atherosclerosis; 1980 Dec; 37(4):625-9. PubMed ID: 7459005
[TBL] [Abstract][Full Text] [Related]
29. Origin and fate of lipoproteins.
Bilheimer DW; Levy RI
Adv Exp Med Biol; 1973; 38():39-52. PubMed ID: 4358292
[No Abstract] [Full Text] [Related]
30. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
31. The carbohydrate composition of human apo low density lipoprotein from normal and type II hyperlipoproteinemic subjects.
Lee P; Breckenridge WC
Can J Biochem; 1976 Jan; 54(1):42-9. PubMed ID: 175902
[TBL] [Abstract][Full Text] [Related]
32. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
Utermann G; Jaeschke M; Menzel J
FEBS Lett; 1975 Aug; 56(2):352-5. PubMed ID: 169165
[No Abstract] [Full Text] [Related]
33. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
[TBL] [Abstract][Full Text] [Related]
34. Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.
Stähelin HB; Locher JT; Maier R
Clin Chim Acta; 1974 Jul; 54(1):115-22. PubMed ID: 4367872
[No Abstract] [Full Text] [Related]
35. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
Bowler A; Redgrave TG; Mamo JC
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
[TBL] [Abstract][Full Text] [Related]
36. Pseudohomozygous and pseudoheterozygous type II hyperlipoproteinemia.
Mishkel MA
Am J Dis Child; 1976 Sep; 130(9):991-3. PubMed ID: 183495
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein of the low density lipoprotein of human plasma: structural study in familial hyperbetalipoproteinemia.
Pinon JC; Turpin G
Clin Chim Acta; 1976 Jul; 70(2):259-65. PubMed ID: 182415
[TBL] [Abstract][Full Text] [Related]
39. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
Bilheimer DW; Stone NJ; Grundy SM
J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
[TBL] [Abstract][Full Text] [Related]
40. Hyperlipoproteinemia type IV and pre-beta-lipoprotein. Some new aspects of its physiology, pathogenesis and diagnosis.
Wille LE
J Oslo City Hosp; 1972; 22(11):169-84. PubMed ID: 4344735
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
